LaSalle Hotel Properties (LHO) Drops 8.28% on January 13

Equities Staff |

LaSalle Hotel Properties (LHO) was one of the Russell 2000's biggest losers for Wednesday January 13 as the stock slid 8.28% to $21.48, a loss of $-1.94 per share. Starting at an opening price of $22.96 a share, the stock traded between $21.45 and $23.26 over the course of the trading day. Volume was 3.2 million shares over 20,390 trades, against an average daily volume of 1.6 million shares and a total float of 112.93 million.

The losses send LaSalle Hotel Properties down to a market cap of $2.43 billion. In the last year, LaSalle Hotel Properties has traded between $43.56 and $23.04, and its 50-day SMA is currently $26.66 and 200-day SMA is $31.48.

The stock has a P/E Ratio of 21.5.

LaSalle Hotel Properties is a real estate investment trust. The Company's business includes buying, owing, redeveloping & leasing mainly upscale & luxury full-service hotels located in convention, resort & urban business markets.

LaSalle Hotel Properties is based out of Bethesda, MD and has some 35 employees. Its CEO is Michael D. Barnello.

For a complete fundamental analysis analysis of LaSalle Hotel Properties, check out’s Stock Valuation Analysis report for LHO. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…